This invention discloses a
KRAS protein degrader modified with
norbornene as a hydrophobic group, its preparation method, and its applications. This invention provides a
protein degrader with
norbornene as the hydrophobic group and MRTX1133 as the
KRAS ligand terminus, capable of selectively binding to
KRAS (preferably the G12D
mutant) and inducing its degradation within cells through a hydrophobic tag, thereby inhibiting downstream oncogenic signaling pathways and suppressing tumor
cell proliferation. One objective of this invention is to provide a general synthetic
route for this type of degrader and several preferred compound examples (denoted as P1~P7), and to demonstrate methods for detecting its KRAS degradation ability and antiproliferative activity in
cell biology experiments (WB,
cell viability assays, etc.).